Discover
VYGR
Voyager Therapeutics, Inc.
2.45
2 x 1.78
6 x 2.44
bid
ask
+
0.08
3.38%
4 @ 04:52 PM
2.49 +0.04 (1.63%)
| Ytd | -37.66% | |
| 1y | -52.43% |
2.35
day range
2.52
2.37
52 week range
5.33
| Open | 2.36 | Prev Close | 2.37 | Low | 2.35 | High | 2.52 | Mkt Cap | 150.96M |
| Vol | 694.39K | Avg Vol | 573.14K | EPS | -1.81 | P/E | N/A | Forward P/E | -3.41 |
| Beta | 0.89 | Short Ratio | 4.44 | Inst. Own | 65.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 3.10 | 200-d Avg | 3.62 | 1yr Est | 17.10 |
| Income Statement | |||
| Total Revenue | 3.17M | ||
| Revenues (USD) | 3.17M | ||
| Gross Profit | 3.17M | ||
| Operating Expenses | 29.56M | ||
| Research and Development Expense | 22.04M | ||
| Selling, General and Administrative Expense | 7.52M | ||
| Operating Income | -26.39M | ||
| Income Tax Expense | 20.00K | ||
| Net Income | -24.47M | ||
| Net Income Common Stock | -24.47M | ||
| Net Income Common Stock (USD) | -24.47M | ||
| Consolidated Income | -24.47M | ||
| Earnings per Basic Share | -0.40 | ||
| Earnings per Basic Share (USD) | -0.40 | ||
| Earnings per Diluted Share | -0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -24.45M | ||
| Earning Before Interest & Taxes (USD) | -24.45M | ||
| Weighted Average Shares | 60.55M | ||
| Weighted Average Shares Diluted | 60.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.51M | ||
| Cash and Equivalents (USD) | 38.51M | ||
| Investments | 113.05M | ||
| Investments Current | 80.57M | ||
| Investments Non-Current | 32.48M | ||
| Trade and Non-Trade Receivables | 3.15M | ||
| Current Assets | 125.23M | ||
| Property, Plant & Equipment Net | 37.10M | ||
| Total Assets | 197.75M | ||
| Debt Current | 6.88M | ||
| Total Debt | 32.57M | ||
| Current Liabilities | 16.68M | ||
| Debt Non-Current | 25.69M | ||
| Total Liabilities | 43.38M | ||
| Accumulated Retained Earnings (Deficit) | -498.31M | ||
| Accumulated Other Comprehensive Income | -421.00K | ||
| Shareholders Equity | 154.38M | ||
| Shareholders Equity (USD) | 154.38M | ||
| Assets Non-Current | 72.53M | ||
| Total Debt (USD) | 32.57M | ||
| Deferred Revenue | 244.00K | ||
| Liabilities Non-Current | 26.69M | ||
| Trade and Non-Trade Payables | 1.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.21M | ||
| Net Cash Flow from Financing | 2.91M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.54M | ||
| Issuance (Purchase) of Equity Shares | 2.91M | ||
| Net Cash Flow from Investing | 15.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 15.39M | ||
| Net Cash Flow from Operations | -25.84M | ||
| Share Based Compensation | 2.43M | ||